A congresswoman with a personal breast cancer story joined imaging experts for a Capitol Hill briefing that served both to illuminate the importance of mammography screening and also condemn recent U.S. Preventive Services Task Force mammography guidelines.

A wave of tomosynthesis adoption is coming, and practices looking to incorporate the modality must make sure their PACS doesn’t limit their viewing or workflow, according to a vendor town hall discussion at the Society for Imaging Informatics in Medicine (SIIM) 2015 annual meeting in National Harbor, Md.

Unprovoked venous thromboembolism may be one of the earliest signs of cancer, with a number of patients going on to receive a diagnosis of cancer in the following year. However, a recent Canadian study found no clinically significant benefit from adding CT to routine screening of venous thromboembolism patients.

Nebraska Native, CEO Dr. Randall Jones, leads the industry with world's first non-invasive wearable PROCURETM (Prostate/Pelvic) MRI Coil.

The U.S. Department of Energy’s Argonne National Laboratory in Illinois has demonstrated the successful production, separation and purification of molybdenum-99 (Mo-99) using a process developed in a public-private partnership with SHINE Medical Technologies.

In Norway, all women aged 50-69 have been invited for biennial breast cancer screening since the Norwegian Breast Cancer Screening Program went national in 2004. This month, the Research Council of Norway submitted its findings on the effectiveness of the program, finding that it has largely met expectations.

While amyloid imaging is typically discussed with regard to diagnosing Alzheimer’s disease, a team of French researchers, presenting at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2015 annual meeting, have found that amyloid scans of the heart can predict major cardiac events.

Post-treatment PET/CT can help diagnose relapses of aggressive non-Hodgkin lymphoma (NHL) cases and spur additional treatment, according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2015 annual meeting in Baltimore.